| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.0054 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |